|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/28 | |
| A61K 9/48 | |||
| A61K 47/48 | |||
| A61K 31/20 |
| (11) | Number of the document | 2688558 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12760271.2 |
| Date of filing the European patent application | 2012-03-23 | |
| (97) | Date of publication of the European application | 2014-01-29 |
| (45) | Date of publication and mention of the grant of the patent | 2015-10-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/KR2012/002134 |
| Date | 2012-03-23 |
| (87) | Number | WO 2012/128587 |
| Date | 2012-09-27 |
| (30) | Number | Date | Country code |
| 20110025940 | 2011-03-23 | KR | |
| 20110041168 | 2011-04-29 | KR |
| (72) |
KIM, Yong Il, KR
YOON, Eun Jin, KR
IM, Ho Taek, KR
SHIN, Yoon Sub, KR
PARK, Jae Hyun, KR
WOO, Jong Soo, KR
|
| (73) |
Hanmi Pharm. Co., Ltd.,
893-5 Hajeo-ri Paltan-myeon Hwaseong-si, Gyeonggi-do 445-910,
KR
|
| (54) | ORAL COMPLEX COMPOSITION COMPRISING OMEGA-3 FATTY ACID ESTER AND HMG-COA REDUCTASE INHIBITOR |
| ORAL COMPLEX COMPOSITION COMPRISING OMEGA-3 FATTY ACID ESTER AND HMG-COA REDUCTASE INHIBITOR |